EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer

被引：0
|
作者：
Moiseyenko, V. [1 ]
Imyanitov, E. [1 ]
Levchenko, E. [1 ]
Procenko, S. [1 ]
Orlova, R. [1 ]
Iyevleva, A. [1 ]
Buslov, K. [1 ]
Ulibina, Y. [1 ]
Matsko, D. [1 ]
Moiseyenko, F. [1 ]
机构：
[1] NN Petrov Oncol Res Inst, St Petersburg, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19075
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EGFR GENE MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER AND ITS INFLUENCE ON EFFECT OF GEFITINIB
    Zhong, W.
    Xia, Y.
    Wang, M-Z
    Chen, M-J
    Zhang, L.
    Zhao, J.
    Li, L-Y
    [J]. RESPIROLOGY, 2011, 16 : 146 - 146
  • [42] AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
    Zhao, Ren
    Zhou, Shun
    Xia, Bing
    Zhang, Cui-ying
    Hai, Ping
    Zhe, Hong
    Wang, Yan-yang
    [J]. BMC CANCER, 2016, 16
  • [43] Regional retrospective analysis of outcomes of EGFR mutated non-squamous non-small cell lung cancer (NSCLC) patients in West Yorkshire
    Sharma, D.
    Slevin, F.
    Clarke, K.
    Franks, K.
    Snee, M.
    Jain, P.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [44] Prognostic impact of TP53 mutations in metastatic non-squamous non-small-cell lung cancer
    Mathiot, Laurent
    Nigen, Benoit
    Goronflot, Thomas
    Hiret, Sandrine
    Doucet, Ludovic
    Pons-Tostivint, Elvire
    Bennouna, Jaafar
    Denis, Marc G.
    Herbreteau, Guillaume
    Raimbourg, Judith
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Kazandjian, Dickran
    Blumenthal, Gideon M.
    Yuan, Weishi
    He, Kun
    Keegan, Patricia
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1307 - 1312
  • [46] Biosimilar TAB008 compared with bevacizumab in advanced non-squamous, non-small cell, EGFR wildtype lung cancer patients
    Zhou, Z.
    Lu, S.
    Qin, S.
    Chen, J.
    Gu, K.
    Sun, P.
    Pan, Y.
    Yu, G.
    Ma, K.
    Shi, J.
    Sun, Y.
    Yang, L.
    Chen, P.
    Liu, A.
    He, J.
    Li, X.
    Wang, L.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1393 - S1394
  • [47] A PROSPECTIVE COHORT STUDY OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH BEVACIZUMAB
    Naoki, Katsuhiko
    Soejima, Kenzo
    Nagase, Seisuke
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Takeda, Yuichiro
    Ikeda, Norihiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S868 - S868
  • [48] A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab
    Naoki, Katsuhiko
    Takeda, Yuichiro
    Soejima, Kenzo
    Arai, Daisuke
    Naka, Go
    Nagase, Seisuke
    Arirnura, Ken
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Ikeda, Norihiko
    [J]. ONCOLOGY LETTERS, 2017, 13 (05) : 3285 - 3290
  • [49] Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
    Lal, R.
    Hillerdal, G. N.
    Shah, R. N. H.
    Crosse, B.
    Thompson, J.
    Nicolson, M.
    Vikstrom, A.
    Potter, V. A.
    Visseren-Grul, C.
    Lorenzo, M.
    D'yachkova, Y.
    Bourayou, N.
    Summers, Y. J.
    [J]. LUNG CANCER, 2015, 89 (02) : 154 - 160
  • [50] Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Shirasawa, Masayuki
    Niwa, Hideyuki
    Kusuhara, Seiichiro
    Harada, Shinya
    Kubota, Masaru
    Katagiri, Masato
    Masuda, Noriyuki
    [J]. ONCOLOGY, 2016, 91 (01) : 41 - 47
12345